Forecyte Bio Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Forecyte Bio Limited - overview
Established
2021
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Based in Shanghai, China and founded in 2021, Forecyte Bio Limited is a company providing CDMO services in the field of cell and gene therapy. The company's CEO Ms. Yingke He worked in GSK for more than 20 years, and has experience in strategy design, project advancement, resource integration, and team building. The company's CTO Dr.
Shuyuan Zhang has nearly 30 years of technical and managerial experience in gene and cell therapy process development and GMP manufacturing. The company's COO Dr. Yujian You has 14 years of business development and marketing experience in the life science field. The company's business includes plasmid production, viral vector production and cell therapy production.
Its virus species include adeno-associated virus, adenovirus, lentivirus, lysozyme virus, retrovirus, etc. Its cellular products include CAR-T, TCR-T, CAR-NK, etc.
Current Investors
Vertex Ventures Southeast Asia & India, BioTrack Capital, Ningbo Hongning Hengtai
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.forecytebio.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Forecyte Bio Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.